Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical agents for preventing the development of tolerance during the treatment with benzodiazepine-receptor-binding active ingredients

Pharmaceutical agents for preventing the development of tolerance during the treatment with benzodiazepine-receptor-binding active ingredients

US Patent 5614509 · Granted Mar 25, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs2010
1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the p2010
Non-invasive drug self-administration system for animals2009
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N2008
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N2008
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N2008
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N2007
Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors fo2007
1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the pr2007
1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the pr2005
1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the pr2005
1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharma2005